Intraoperative radiation therapies are cutting-edge techniques used during surgery to deliver targeted radiation directly to tumor sites. This approach ensures precise treatment, minimizing damage to surrounding healthy tissues. With applications in various cancer treatments, they enhance the effectiveness of surgical interventions, reducing the need for follow-up treatments. Intraoperative radiation therapies offer real-time precision and convenience by combining surgery and radiation delivery, thus representing a significant advancement in oncology for improved patient outcomes.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-intraoperative-radiation-therapy-market
Data Bridge Market Research analyses that the Global Intraoperative Radiation Market is valued at USD 283.94 million in 2022 and is expected to reach USD 498.91 million by 2030, registering a CAGR of 8.7% during the forecast period of 2023 to 2030. Intraoperative therapies are benefiting from the continuous development of minimally invasive and image-guided surgical techniques, which are increasing the demand for such therapies, thus driving the market’s growth.
Key Findings of the Study
Focus on precision medicine is expected to drive the market's growth rate
Intraoperative therapies are vital in personalized medicine, as they facilitate precise treatments during surgery. This aligns seamlessly with the overarching trend of precision medicine in healthcare. Offering targeted interventions tailored to individual patient needs, these therapies enhance surgical outcomes and contribute to a patient-centered approach. This integration of intraoperative therapies with precision medicine underscores the medical field's commitment to optimizing treatments and achieving better patient results.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Thousand, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Method (Electron, Intraoperative Brachytherapy, High Dose-Rate, X-Ray, and Others), Product (Intraoperative Radiation Therapy Devices, Intraoperative Radiation Therapy Accessories, and Software and Services), Type (Portable and Benchtop), Application (Breast Cancer, Brain Tumor, Head and Neck Cancer, Soft Tissue Sarcoma, Pediatric Tumors, Gynecological Cancer, Genitourinary Cancers, and Upper Gastro-Intestinal Tumors Other Cancer), End User (Hospital, Ambulatory Surgical Centers, Specialty Center, and Others), Distribution Channel (Direct Tender and Retail Sales)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
ntraOp Medical, Inc (U.S.), Varian Medical Systems, Inc (U.S.), Eckert & Ziegler (Germany), Sensus Healthcare (U.S.)., Elekta (Sweden)., REMEDI Co., Ltd (South Korea), Brainlab AG (Germany), Sensus Healthcare (U.S.), Elekta (Sweden)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
|
Segment Analysis:
The intraoperative radiation market is segmented on the basis of method, product, type, application, end user, and distribution channel.
- On the basis of method, the global intraoperative radiation market is segmented into electron, intraoperative brachytherapy, high dose-rate, x-ray, and others.
- On the basis of product, the global intraoperative radiation market is segmented into intraoperative radiation therapy devices, intraoperative radiation therapy accessories, and software and services.
- On the basis of type, the global intraoperative radiation market is segmented into portable and benchtop.
- On the basis of application, the global intraoperative radiation market is segmented into breast cancer, brain tumor, head and neck cancer, soft tissue sarcoma, pediatric tumors, gynecological cancer, genitourinary cancers, and upper gastro-intestinal tumors other cancer.
- On the basis of end user, the global intraoperative radiation market is segmented into hospital, ambulatory surgical centers, specialty center, and others.
- On the basis of distribution channel, the global intraoperative radiation market is segmented into direct tender and retail sales.
Major Players
Data Bridge Market Research recognizes the following companies as the major intraoperative radiation market players in intraoperative radiation market are ntraOp Medical, Inc (U.S.), Varian Medical Systems, Inc (U.S.), Eckert & Ziegler (Germany), Sensus Healthcare (U.S.)., Elekta (Sweden)., REMEDI Co., Ltd (South Korea), Brainlab AG (Germany), Sensus Healthcare (U.S.), Elekta (Sweden)
Market Development
- In 2021, Varian Medical Systems, Inc. has entered into a partnership with Australia's Icon Group, aiming to supply 30 linear accelerators and related treatment software to combat the worldwide cancer challenge. This collaboration will bolster the company's efforts to expand healthcare access across underserved regions in Australia and Asia, contributing to improved care delivery and enhanced patient outcomes.
Regional Analysis
Geographically, the countries covered in the Intraoperative radiation market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in the intraoperative radiation market during the forecast period 2023 - 2030
In 2023, North America dominated the intraoperative radiation market due to continuous efforts in launching novel offerings and sustained investment in research and development initiatives underscore the commitment to streamlining operational procedures. This dedication extends to ensuring the widespread accessibility of genuine medical-grade imaging systems. The collective drive of these factors in the region promotes advanced healthcare solutions, fostering a dynamic environment that prioritizes both technological advancement and effective medical outcomes.
For more detailed information about the intraoperative radiation market report, click here – https://www.databridgemarketresearch.com/reports/global-intraoperative-radiation-therapy-market
